Kraig Biocraft Laboratories, Inc. has entered an agreement with the Vietnam Sericulture Association (VSA), marking a significant leap forward for the company's production ambitions. The agreement, disclosed today, unveils Kraig Labs' production plans for the next twenty-four months to the VSA, fostering a collaborative effort aimed at meeting production targets.
Central to the agreement is the VSA's commitment to aid Kraig Labs in securing formal intellectual property registration of its BAM-1 hybrid silkworm strain in Vietnam, reinforcing the partnership established in the Memorandum of Understanding earlier this year.
"This agreement signifies years of concerted efforts with various agencies to showcase our technology and its potential," stated Kim K. Thompson, Founder and CEO of Kraig Biocraft Laboratories. Thompson emphasized the strategic significance of the partnership with the VSA in advancing production goals and strengthening the company's foothold in Southeast Asia.
Le Quang Tu, President of the Vietnamese Sericulture Association, expressed optimism about the collaboration, citing Kraig's technology as a potential game-changer for the industry.
With CEO Kim K. Thompson on-site in Vietnam to oversee operations, Kraig Labs anticipates forthcoming updates on its accelerating progress in the weeks ahead. This landmark agreement underscores the company's commitment to innovation and strategic partnerships in revolutionizing the sericulture industry.
